114 related articles for article (PubMed ID: 2399258)
1. Luteinizing hormone secretion as a response to a second naltrexone administration.
Yogev L; Gottreich A; Homonnai ZT; Yavetz H; Paz GF
Proc Soc Exp Biol Med; 1990 Oct; 195(1):22-5. PubMed ID: 2399258
[TBL] [Abstract][Full Text] [Related]
2. Opiate system involvement in the control of LH secretion in diabetic and normoglycemic male rats.
Yogev L; Gottreich A; Brezner E; Paz GF; Homonnai ZT
Life Sci; 1987 Aug; 41(5):585-90. PubMed ID: 3600195
[TBL] [Abstract][Full Text] [Related]
3. Blood luteinizing hormone and prolactin concentrations in response to naltrexone challenge: studies on rats with diabetes induced by different doses of streptozotocin.
Yogev L; Yavetz H; Gottreich A; Oppenheim D; Homonnai ZT; Paz G
Life Sci; 1994; 54(4):261-6. PubMed ID: 8289586
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone-induced LH release in ovariectomized estrogen-primed rats.
Higuchi T; Kawakami M
Endocrinol Jpn; 1981 Feb; 28(1):45-50. PubMed ID: 7250068
[TBL] [Abstract][Full Text] [Related]
5. Possible dopaminergic system involvement in LH and PRL responses to naltrexone treatment.
Yogev L; Gottreich A; Homonnai ZT; Paz GF
Life Sci; 1989; 45(24):2343-9. PubMed ID: 2601582
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat.
Briski KP; Vogel KL
Neuropeptides; 1995 Mar; 28(3):175-81. PubMed ID: 7791961
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of naltrexone on luteinizing hormone release during single versus repetitive exposure to restraint stress.
Briski KP; Sylvester PW
Psychoneuroendocrinology; 1992; 17(2-3):125-33. PubMed ID: 1332097
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opiate involvement in acute and chronic stress-induced changes in plasma LH concentrations in the male rat.
Briski KP; Quigley K; Meites J
Life Sci; 1984 Jun; 34(25):2485-93. PubMed ID: 6374352
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic effects of the new opioid antagonist naltrexone-estrone azine on pituitary luteinizing hormone secretion in ovariectomized rats.
Armeanu MC; van Dieten JA; Kolb VM; Schoemaker J; de Koning J
Life Sci; 1992; 50(13):913-21. PubMed ID: 1548976
[TBL] [Abstract][Full Text] [Related]
10. Elicitation of release of luteinizing hormone by N-methyl-d,l-aspartic acid during three paradigms of suppressed secretion of luteinizing hormone in the female pig.
Sesti LA; Britt JH
Domest Anim Endocrinol; 1992 Apr; 9(2):105-14. PubMed ID: 1617956
[TBL] [Abstract][Full Text] [Related]
11. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
[TBL] [Abstract][Full Text] [Related]
12. Advancement of first ovulation by the opioid antagonist naltrexone.
Meijs-Roelofs HM; Kramer P
Biol Reprod; 1989 Nov; 41(5):842-7. PubMed ID: 2624852
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone attenuates stress-induced suppression of LH secretion in the pituitary gland in the Cichlid fish Oreochromis mossambicus: evidence for the opioidergic mediation of reproductive stress response.
Ganesh CB; Chabbi A
Fish Physiol Biochem; 2013 Jun; 39(3):627-36. PubMed ID: 23053608
[TBL] [Abstract][Full Text] [Related]
14. Effects of the opioid antagonist naltrexone-estrone azine on the luteinizing hormone-releasing hormone induced release of luteinizing hormone from the pituitary glands of ovariectomized rats.
Armeanu MC; van Dieten JA; Kolb VM; Schoemaker J; de Koning J
Life Sci; 1993; 52(15):1311-8. PubMed ID: 8464327
[TBL] [Abstract][Full Text] [Related]
15. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
[TBL] [Abstract][Full Text] [Related]
16. Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome.
Cagnacci A; Soldani R; Paoletti AM; Falqui A; Melis GB
Fertil Steril; 1994 Aug; 62(2):269-72. PubMed ID: 8034071
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone does not reverse the inhibitory effect of chronic restraint on gonadotropin secretion in the intact male rat.
González-Quijano MI; Ariznavarreta C; Martín AI; Treguerres JA; López-Calderón A
Neuroendocrinology; 1991 Nov; 54(5):447-53. PubMed ID: 1749459
[TBL] [Abstract][Full Text] [Related]
18. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.
Veldhuis JD; Rogol AD; Johnson ML
J Clin Invest; 1983 Dec; 72(6):2031-40. PubMed ID: 6315775
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic luteinizing hormone releasing factor and corticotrophin releasing activity in relation to pituitary and plasma hormone levels in male and female rats.
Chiappa SA; Fink G
J Endocrinol; 1977 Feb; 72(2):195-210. PubMed ID: 191558
[TBL] [Abstract][Full Text] [Related]
20. Effects of opioid antagonism with naltrexone on pulsatile luteinizing hormone secretion in women with hypothalamic amenorrhea in basal conditions and after discontinuation of treatment with pulsatile LHRH.
Armeanu MC; Lambalk CB; Berkhout GM; Schoemaker J
Gynecol Endocrinol; 1992 Mar; 6(1):3-12. PubMed ID: 1580165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
